Muscoflex (Thiocolchicoside)

Thiocolchicoside acts as a competitive antagonist at glycine receptors and GABA‑A receptors in the spinal cord. By blocking these inhibitory neurotransmitter sites, it diminishes spinal reflex activity, leading to reduced muscle tone and relaxation of skeletal muscles.

The dosage of Muscoflex is determined by the prescribing clinician based on the patient’s condition, severity of symptoms and clinical response. The prescriber selects the appropriate volume and frequency of intramuscular injection in accordance with local guidelines.

The safety of thiocolchicoside in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Muscoflex product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other skeletal muscle relaxants such as baclofen or tizanidine, thiocolchicoside has a distinct mechanism targeting glycine and GABA‑A receptors, which may result in a different side‑effect profile. Clinical choice depends on efficacy, tolerability, patient comorbidities and physician experience.

Muscoflex should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. The product should remain in its original packaging until use to maintain sterility and potency.

Muscoflex is supplied as a sterile solution for intramuscular injection. A qualified healthcare professional administers the appropriate volume into a muscle, typically the gluteal or deltoid region, following aseptic technique and according to the prescribed dosing schedule.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, significant hypotension, hepatotoxicity, Stevens‑Johnson syndrome, profound muscle weakness and seizures. Immediate medical attention is required if any of these events occur.

Muscoflex is contraindicated in patients with known hypersensitivity to thiocolchicoside or any excipients, and should be avoided in individuals with severe hepatic impairment, uncontrolled epilepsy, or those taking other central nervous system depressants without close monitoring. Consultation with a healthcare provider is essential before use.